Lumbar Degenerative Disc Disease Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Lumbar Degenerative Disc Disease Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Drug Treatment, Biologics, Other), By Route of administration (Oral, Injectables, Other), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The Global Lumbar Degenerative Disc Disease Market is projected to expand significantly, from USD 9.67 billion in 2025 to USD 14.33 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 6.78%. This market encompasses various medical interventions, including pharmaceuticals and spinal implants like artificial discs and fusion devices, all aimed at pain management and restoring stability in the lower spine. Key growth drivers include the increasing global geriatric population and rising rates of obesity, both contributing to accelerated spinal deterioration, along with sedentary lifestyles weakening spinal musculature and elevating the incidence of lower back conditions requiring medical intervention. However, the market faces significant challenges from the high cost of spinal surgeries and restrictive reimbursement policies, which limit patient access to advanced treatments; these financial obstacles are often exacerbated by rigorous regulatory approval processes for new technologies, potentially slowing the introduction of innovative solutions, with annual spending on spine care in the U.S. alone surpassing $85 billion in 2024, according to the North American Spine Society, highlighting the substantial economic burden.
Market Driver
A key market driver is the increasing integration of robotic-assisted spinal surgery, which is transforming clinical outcomes in lumbar degenerative disc disease by improving screw placement accuracy and decreasing intraoperative radiation exposure; these advanced systems enable minimally invasive procedures, significantly shortening recovery periods and reducing surgical complications, thus boosting hospital adoption and justifying substantial capital expenditures, exemplified by Globus Medical's Q2 2024 earnings call (August 2024) reporting a 59% year-over-year growth in robot unit placements, and Medtronic's Cranial and Spinal Technologies division generating $1.2 billion in quarterly revenue in Q2 FY2025 (November 2024) largely due to integrated enabling technologies and spinal implants. Concurrently, the accelerating growth of the global geriatric population is a crucial demographic driver, as natural aging inherently causes intervertebral disc and spinal structure deterioration; with rising global life expectancy, increased mechanical stress on the lumbar spine leads to a higher incidence of complex conditions such as spinal stenosis and spondylolisthesis, necessitating medical intervention, a significant public health issue highlighted by a November 2024 article in Frontiers in Public Health stating that around 628.8 million people globally suffered from low back pain in 2021, a number consistently increasing with aging demographics, thus ensuring a continuous demand for both therapeutic and surgical management strategies for lumbar degenerative disc disease across all healthcare systems.
Market Challenge
The Global Lumbar Degenerative Disc Disease Market faces considerable obstacles due to the rising costs of spinal procedures and a progressively stricter reimbursement landscape; healthcare systems, aiming to control expenses, impose rigorous criteria for surgical approval, leading to frequent claim rejections and delayed payments for advanced spinal interventions, a financial strain that compels hospitals and surgical centers to restrict their stock of premium implants and defer the adoption of newer, more expensive technologies, thereby impeding market growth. Consequently, the financial feasibility of performing complex lumbar surgeries is decreasing for many providers, as reimbursement rates often fail to match the increasing operational costs of surgery, causing the adoption of innovative fusion devices and artificial discs to stall; data from the American Academy of Orthopaedic Surgeons in 2025 indicated a 26.2% decrease in average reimbursements for orthopedic surgeries over an eight-year period, a significant reduction in financial compensation that forces medical professionals to prioritize cost control over technological progress, directly hindering revenue generation for industry participants.
Market Trends
A prominent market trend is the shift of lumbar procedures to ambulatory surgery centers (ASCs), driven by the economic necessity to lower healthcare costs and advancements in minimally invasive techniques that enable safe, same-day discharge; this transition moves routine spinal decompressions and fusions out of costly hospital settings, providing significant savings for payers and a more efficient patient experience, a rapid growth in outpatient capacity supported by a December 2024 survey by Compass Surgical Partners, where 53% of ASC leaders were planning to expand their spine service lines in 2025 to meet rising demand. Simultaneously, the acceleration of regenerative medicine and cell-based therapies is tackling the critical clinical issue of pseudarthrosis by improving biological fusion rates, especially in patients with poor bone quality; manufacturers are increasingly focusing on developing and commercializing advanced bone growth therapies and bioactive matrices that promote osteogenesis more effectively than traditional autografts, with this emphasis on biological effectiveness yielding significant commercial benefits as Orthofix Medical Inc. reported record net sales of $63.9 million for their Bone Growth Therapies segment in Q4 2024 (February 2025), a 9% increase year-over-year, underscoring the market's growing reliance on complementary solutions for achieving durable spinal stability.
Key Market Players
* Medtronic plc
* Johnson & Johnson Services, Inc.
* Stryker Corporation
* Zimmer Biomet Holdings, Inc.
* NuVasive, Inc.
* Globus Medical, Inc.
* Orthofix Medical Inc.
* SeaSpine Holdings Corporation
* RTI Surgical Holdings, Inc.
* Alphatec Holdings, Inc.
Report Scope
In this report, the Global Lumbar Degenerative Disc Disease Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Lumbar Degenerative Disc Disease Market, By Treatment Type
* Drug Treatment
* Biologics
* Other
# Lumbar Degenerative Disc Disease Market, By Route of administration
* Oral
* Injectables
* Other
# Lumbar Degenerative Disc Disease Market, By End User
* Hospitals & Clinics
* Ambulatory Care Centers
* Others
# Lumbar Degenerative Disc Disease Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Lumbar Degenerative Disc Disease Market.
Available Customizations:
Global Lumbar Degenerative Disc Disease Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Lumbar Degenerative Disc Disease Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Treatment Type (Drug Treatment, Biologics, Other)
5.2.2. By Route of administration (Oral, Injectables, Other)
5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. North America Lumbar Degenerative Disc Disease Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Treatment Type
6.2.2. By Route of administration
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Lumbar Degenerative Disc Disease Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Treatment Type
6.3.1.2.2. By Route of administration
6.3.1.2.3. By End User
6.3.2. Canada Lumbar Degenerative Disc Disease Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Treatment Type
6.3.2.2.2. By Route of administration
6.3.2.2.3. By End User
6.3.3. Mexico Lumbar Degenerative Disc Disease Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Treatment Type
6.3.3.2.2. By Route of administration
6.3.3.2.3. By End User
7. Europe Lumbar Degenerative Disc Disease Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Treatment Type
7.2.2. By Route of administration
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Lumbar Degenerative Disc Disease Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Treatment Type
7.3.1.2.2. By Route of administration
7.3.1.2.3. By End User
7.3.2. France Lumbar Degenerative Disc Disease Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Treatment Type
7.3.2.2.2. By Route of administration
7.3.2.2.3. By End User
7.3.3. United Kingdom Lumbar Degenerative Disc Disease Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Treatment Type
7.3.3.2.2. By Route of administration
7.3.3.2.3. By End User
7.3.4. Italy Lumbar Degenerative Disc Disease Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Treatment Type
7.3.4.2.2. By Route of administration
7.3.4.2.3. By End User
7.3.5. Spain Lumbar Degenerative Disc Disease Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Treatment Type
7.3.5.2.2. By Route of administration
7.3.5.2.3. By End User
8. Asia Pacific Lumbar Degenerative Disc Disease Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Treatment Type
8.2.2. By Route of administration
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Lumbar Degenerative Disc Disease Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Treatment Type
8.3.1.2.2. By Route of administration
8.3.1.2.3. By End User
8.3.2. India Lumbar Degenerative Disc Disease Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Treatment Type
8.3.2.2.2. By Route of administration
8.3.2.2.3. By End User
8.3.3. Japan Lumbar Degenerative Disc Disease Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Treatment Type
8.3.3.2.2. By Route of administration
8.3.3.2.3. By End User
8.3.4. South Korea Lumbar Degenerative Disc Disease Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Treatment Type
8.3.4.2.2. By Route of administration
8.3.4.2.3. By End User
8.3.5. Australia Lumbar Degenerative Disc Disease Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Treatment Type
8.3.5.2.2. By Route of administration
8.3.5.2.3. By End User
9. Middle East & Africa Lumbar Degenerative Disc Disease Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Treatment Type
9.2.2. By Route of administration
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Lumbar Degenerative Disc Disease Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Treatment Type
9.3.1.2.2. By Route of administration
9.3.1.2.3. By End User
9.3.2. UAE Lumbar Degenerative Disc Disease Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Treatment Type
9.3.2.2.2. By Route of administration
9.3.2.2.3. By End User
9.3.3. South Africa Lumbar Degenerative Disc Disease Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Treatment Type
9.3.3.2.2. By Route of administration
9.3.3.2.3. By End User
10. South America Lumbar Degenerative Disc Disease Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Treatment Type
10.2.2. By Route of administration
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Lumbar Degenerative Disc Disease Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Treatment Type
10.3.1.2.2. By Route of administration
10.3.1.2.3. By End User
10.3.2. Colombia Lumbar Degenerative Disc Disease Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Treatment Type
10.3.2.2.2. By Route of administration
10.3.2.2.3. By End User
10.3.3. Argentina Lumbar Degenerative Disc Disease Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Treatment Type
10.3.3.2.2. By Route of administration
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Lumbar Degenerative Disc Disease Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Medtronic plc
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Johnson & Johnson Services, Inc.
15.3. Stryker Corporation
15.4. Zimmer Biomet Holdings, Inc.
15.5. NuVasive, Inc.
15.6. Globus Medical, Inc.
15.7. Orthofix Medical Inc.
15.8. SeaSpine Holdings Corporation
15.9. RTI Surgical Holdings, Inc.
15.10. Alphatec Holdings, Inc.
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們